SCHEMBL8554816

SCHEMBL8554816

[CH2]Cc1ccc(OC)c(OCc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.59
HSD17B10 Q99714 1/20 0.59
ABCB1 P08183 2/20 0.57
ABCG2 Q9UNQ0 1/20 0.57
KDM4E B2RXH2 3/20 0.56
LMNA P02545 2/20 0.56
HTT P42858 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
KMT2A Q03164 2/20 0.56
NPY1R P25929 1/20 0.56
NPY2R P49146 1/20 0.56
BCHE P06276 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
BLM P54132 1/20 0.56
ALDH1A1 P00352 2/20 0.55
SMPD1 P17405 1/20 0.55
HDAC1 Q13547 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8556952 0.94 MEN1 (0.60) HSD17B10ABCB1ABCG2KDM4ELMNA
SCHEMBL7208378 0.90 SLC2A1 (0.52) MAPK1HSD17B10KDM4ELMNAHTT
SCHEMBL8554822 0.85 MAPK1 (0.64) MAPK1HSD17B10ABCB1ABCG2KDM4E
SCHEMBL6672350 0.84 TTR (0.60) MAPK1HSD17B10ABCB1ABCG2KDM4E
SCHEMBL31361425 0.84 BCHE (0.60) MAPK1HSD17B10ABCB1ABCG2KDM4E
SCHEMBL2060386 0.84 MAPK1 (0.63) MAPK1HSD17B10ABCB1ABCG2KDM4E
SCHEMBL3239903 0.84 BCHE (0.60) MAPK1HSD17B10ABCB1ABCG2KDM4E
SCHEMBL3722770 0.84 MAPK1 (0.59) MAPK1HSD17B10ABCB1ABCG2KDM4E
SCHEMBL10731044 0.83 ALDH1A1 (0.69) MAPK1HSD17B10ABCB1ABCG2KDM4E
Phosphine SCHEMBL4434544 0.83 TTR (0.59) MAPK1HSD17B10ABCB1ABCG2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0617022-B1 6,7, dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound BANYU PHARMA CO LTD (JP) 1998-02-11 EP disclosed
US-5498717-A CHEMICAL INTERMEDIATES FOR PRODUCING ANTITUMOR POTENTIATORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-03-12 US disclosed
US-5446164-A Regioselective cyclization of phenethylamide derivative in presence of phosphoric acid halide, reducing formed compound BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-29 US disclosed